Vaccine: Pfizer Withdraws Emergency Use Authorization Plea In India

American pharmaceutical MNC Pfizer has withdrawn the Emergency Use Authorization application for its COVID-19 vaccine in India. Pfizer on February 5 said the decision had been taken after it met with the Drug Regulatory Authority of India. Withdrawing its request, the vaccine developer said the regulator has sought for extra information. However, Pfizer, which was first to seek emergency approval for the vaccine in India, has confirmed to re-apply.